SCHEMBL23913442

SCHEMBL23913442

c1ccc(-c2cccc3oc4cc(-c5nc(-c6ccc(-c7cccc8sc9ccccc9c78)cc6)nc(-c6ccc7c(c6)oc6ccccc67)n5)ccc4c23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 1/20 0.35
HCRTR1 O43613 1/20 0.34
SLC9A1 P19634 1/20 0.34
BACE1 P56817 1/20 0.34
BRDT Q58F21 1/20 0.34
PRKDC P78527 1/20 0.34
AHR P35869 1/20 0.33
LIMK1 P53667 1/20 0.33
MAPT P10636 4/20 0.33
ALOX5 P09917 1/20 0.33
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 4/20 0.33
HPGD P15428 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
HSD17B10 Q99714 2/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25646009 0.98 F9 (0.36) F9HCRTR1SLC9A1BRDTPRKDC
SCHEMBL23913828 0.97 PRKDC (0.35) F9HCRTR1SLC9A1BACE1BRDT
SCHEMBL25645656 0.97 F9 (0.36) F9HCRTR1SLC9A1BRDTPRKDC
SCHEMBL25645611 0.97 F9 (0.36) F9HCRTR1SLC9A1BRDTPRKDC
SCHEMBL23822340 0.96 PRKDC (0.35) F9HCRTR1SLC9A1BACE1BRDT
SCHEMBL23820918 0.96 PRKDC (0.36) F9HCRTR1SLC9A1BACE1BRDT
SCHEMBL26194114 0.96 BRDT (0.36) F9HCRTR1SLC9A1BRDTPRKDC
SCHEMBL23913450 0.96 HCRTR1 (0.37) F9HCRTR1SLC9A1BRDTPRKDC
SCHEMBL25645660 0.94 HCRTR1 (0.36) F9HCRTR1SLC9A1BRDTPRKDC
SCHEMBL26196569 0.94 PRKDC (0.36) F9HCRTR1SLC9A1BACE1BRDT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 F9 1646/4885HCRTR1 476/4885SLC9A1 1628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.